Notizie

È possibile consultare le ultime notizie, articoli e annunci su EndoPredict qui sotto o visitare la pagina ufficiale dei comunicati stampa di Myriad Genetics.

Guarda il simposio satellite dell'industria di Myriad Genetics all'ESMO 2022

September 19, 2022

Dovremmo usare le firme genetiche per decidere la chemioterapia nelle pazienti ER+/HER2- in premenopausa? La dott.ssa Anastasia Constantinidou condivide i nuov...

EndoPredict informs treatment decisions for premenopausal breast cancer

August 31, 2022

New publication shows EndoPredict Breast Cancer Prognostic Test accurately identified premenopausal women with ER+, HER2- breast cancer who could safely avoid ...

High adherence to EndoPredict test results in extended endocrine therapy decision making in early breast cancer

June 22, 2022

Clinicians demonstrated up to 100% adherence to EndoPredict test results in extended endocrine therapy decision making As a leader in genetic testing and pr...